Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The European Banking Authority has warned the market to expect a sharp deterioration in asset quality next year, after publishing a wealth of new information on provisioning practices. -
Travel and leisure companies are expected to be active issuers in the equity capital markets in 2021, as they ride out a difficult winter next year.
-
AstraZeneca, the UK pharmaceuticals company, has lined up $17.5bn of bridge loans from three banks to back its $39bn acquisition of US biotech firm Alexion.
-
Chinese healthcare technology company Yidu Tech is set to begin drumming up demand for its Hong Kong IPO after winning listing approval from the city’s bourse.
-
Ukraine, which has proven itself a favourite of emerging market investors this year, has slipped into international markets for a small dollar tap before year-end. The trade comes amid strained negotiations between Ukraine and the IMF over the disbursement of emergency funding.
-
The European Banking Authority has updated the market on how it thinks Basel IV will impact bank capital requirements, setting the scene for another paper next week examining how the rules could interact with the economic shock of the coronavirus pandemic.
